Shares in medical dermatology company Botanix Pharmaceuticals, led by Perth-based chairman Graham Griffiths and executive director Matt Callahan, have jumped more than 20 per cent today after the company announced successful results from an acne patient study.
Related Data & Insights
-
Botanix PharmaceuticalsClosing price for the last 90 trading daysPowered by Morningstar ®
-
Rank Company Revenue 132nd Botanix Pharmaceuticals $3.8m 133rd Volt Power Group $3.6m 134th Wellfully $3.3m 136th Proteomics International Laboratories $3.2m 137th Adisyn $2.9m 200 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Related Articles
27 Nov 2023
Botanix taps investors for $13.5m
25 Aug 2023
Board Moves August 25, 2023
21 Aug 2023
Board Moves August 21, 2023
21 Jul 2023
Botanix secures $12.5m placement
17 Apr 2023
Board Moves April 17, 2023
05 Apr 2023
Botanix to raise $10m
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX